메뉴 건너뛰기




Volumn 285, Issue 27, 2010, Pages 20607-20614

Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1β activity

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR SIGNALING; CONTEXT DEPENDENT; CYTOKINES; EFFECTIVE DOSE; HIGH ACTIVITY; IN-VITRO; INTERLEUKIN-1; KINETIC APPROACH; LIGAND BINDING; POTENT INHIBITOR; REGULATORY MECHANISM; REGULATORY PROTEIN; SIGNALING PATHWAYS; SIGNALING RECEPTOR; THERAPEUTIC ANTIBODIES; THERAPEUTIC USE;

EID: 77954224428     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M110.115790     Document Type: Article
Times cited : (43)

References (42)
  • 28
    • 62649128371 scopus 로고    scopus 로고
    • Donath, M. (2008) Diabetologia 51 (suppl 1), S7
    • (2008) Diabetologia , vol.51 , Issue.SUPPL. 1
    • Donath, M.1
  • 34
    • 77954224552 scopus 로고    scopus 로고
    • April 1, U. S. Patent Application 20040063913
    • Gram, H., and Di Padova, F. E. (April 1, 2004) U. S. Patent Application 20040063913
    • (2004)
    • Gram, H.1    Di Padova, F.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.